Fuisz
This article was originally published in The Tan Sheet
Executive Summary
Contract with McNeil for development of Flash Dose acetaminophen product terminated, Fuisz says March 24; the company is "already in negotiation with a number of companies interested in acquiring marketing rights to Flash Dose acetaminophen." Fuisz expects to select a partner and launch the product in the U.S. by the end of the year. The company has re-negotiated three other early contracts to transfer manufacturing rights back to Fuisz. Remaining OTC product partners include SmithKline Beecham and Whitehall-Robins...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning